Interní Med. 2019; 21(2): 84-87 | DOI: 10.36290/int.2019.041

Current trends in the use of fixed combinations in treating diabetes

MUDr. Jana Vyoralová
Diabetologická ambulance, Veselí nad Moravou

Type 2 diabetes mellitus is a chronic progressive disease which patients can live with for decades. They are given many recommendations
regarding lifestyle changes, diet, and exercise. Moreover, they also have to take medications according to current recommendations, the
number of which increases with increasing duration of the disease. This concerns not only the treatment with antidiabetic drugs, but also
concurrent hypolipidemic medication, antihypertensives, etc. A large number of pills used during the day leads to their omitting, thus
lowering the overall effect. Fixed combinations of drugs administered by mouth or by injection certainly increase adherence to treatment.

Keywords: type 2 diabetes mellitus, sdherence, antidiabetic drugs, fixed combinations

Received: June 25, 2018; Accepted: June 25, 2018; Published: May 10, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vyoralová J. Current trends in the use of fixed combinations in treating diabetes. Interní Med. 2019;21(2):84-87. doi: 10.36290/int.2019.041.
Download citation

References

  1. Dle ÚZIS.
  2. DeFronzo RA. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Lancet 2009. Dostupné na https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661582/ Go to original source...
  3. Svačina Š. Antidiabetika - historie, současnost a perspektivy, Axonite CZ 2016, 39-40.
  4. Šmahelová A. Pioglitazon - využití v léčbě diabetika 2. typu. Kapitoly z kardiologie, 2013, 4, 122-125.
  5. SPC Actos
  6. Pelikánová T, Bartoš a kol. Praktická diabetologie, Maxdorf Jessenius 2011.
  7. Haluzí, M.A. kol. Ledviny a léčba diabetu: současnost a perspektivy terapie glifloziny, Mladá fronta 2017.
  8. Práznovcová L. Compliance pacienta. Dostupné na https://www.pace.cz/wp-content/uploads/2013/03/5_compliance_pacienta.pdf
  9. Motlová L., Holub D. Compliance a adherence: spolupráce při léčbě. Dostupné na http://www.remedia.cz/Okruhy-temat/Psychiatrie/Compliance-a-adherence-spoluprace-pri-lecbe/8-1n-bl.magarticle.aspx
  10. New EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes launched at EASD meeting. New recommendations include specific drug classes for some patients and enhancing medication adherence. Dostupné na https://diabetologia-journal.org/2018/10/05/new-easd-ada-consensus-guidelines-on-managing-hyperglycaemia-in-type-2-diabetes-launched-at-easd-meeting-new-recommendations-include-specific-drug-classes-for-some-patients-and-enhancing-medication-a/
  11. Dle www.diab.cz
  12. Bilz FE. Nové léčení přirozené, díl první, nákladem autora, F. Legel Dampfbuchbinderei Leipzig r. 1901.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.